Goldfinch Biopharma Company

Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease.

Funding Status: Early Stage Venture
Industry: PharmTech
Estimated Revenue: $1M to $10M
Technology: Neurological Disorders
Headquarters: Cambridge, Massachusetts, United States
Employee Number: 11-50
Founded Date: 2015